About
Elekta is a leading innovator in precision radiation therapy, radiosurgery, and related software for the treatment of cancer and brain disorders. With a strong commitment to advancing clinical outcomes, Elekta develops cutting-edge solutions that enhance the accuracy and effectiveness of radiotherapy. Their technologies, such as the Elekta Unity and Versa HD, are widely recognized for transforming patient care and improving survival rates.
Founded in 1972, Elekta has grown into a global healthcare company with a presence in over 120 countries. Their dedication to research and development has positioned them as a key player in the fight against cancer, continuously pushing the boundaries of medical technology. Elekta’s collaborative approach with healthcare professionals ensures their innovations meet the evolving needs of patients and clinicians alike.
Elekta also prioritizes education and training, providing comprehensive support to medical professionals worldwide. Their commitment to professional development ensures the optimal use of their advanced technologies, ultimately enhancing patient outcomes. By fostering a culture of continuous learning and innovation, Elekta remains at the forefront of the radiotherapy and radiosurgery fields, driving progress in cancer treatment.
